📢 Current Oncology was awarded an increased Impact Factor of 2.8 in the 2023 Journal Citation Reports™ released by Clarivate in June 2024. ⬆️ The ranking of Current Oncology has been upgraded from Q3 to Q2 (157 out of 322 titles) in the "Oncology" category! 👉 Welcome to read more details here: https://brnw.ch/21wKWm0
Current Oncology MDPI
Zeitschriftenverlage
An international, peer-reviewed, open access journal on clinical oncology practice published online by MDPI.
Info
Current Oncology (ISSN 1718-7729) represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy to report upon and to review progress in the management of this disease. Articles published in the journal typically contain information that is relevant directly to clinical oncology practice, and have clear potential for application to the current or future practice of cancer medicine.
- Website
-
https://www.mdpi.com/journal/curroncol
Externer Link zu Current Oncology MDPI
- Branche
- Zeitschriftenverlage
- Größe
- 11–50 Beschäftigte
- Hauptsitz
- Basel
- Art
- Privatunternehmen
Orte
-
Primär
Grosspeteranlage 5
Basel, 4052, CH
Beschäftigte von Current Oncology MDPI
Updates
-
📢 Happy to share the Special Issue "Haematological Neoplasms: Diagnosis and Management" led by Prof. Dr. Stefano Ascani, Prof. Dr. Francesca Sanguedolce and Dr. Magda Zanelli. 👏 18 papers have been published! Find more details here👉 https://brnw.ch/21wMjjd
-
-
Current Oncology MDPI hat dies direkt geteilt
I am pleased to share our last research article, realized with Università degli Studi di Padova - Istituto di Radiologia, and published today in the journal Current Oncology MDPI. The topic was the development of a predictive model based on radiomic features, with a Machine Learning algorithm, aimed at recognizing adrenal incidentalomas that are at risk of presenting subclinical cortisol hormone secretion, which is linked to increased cardiovascular risk. Elena Agostini, Filippo Ceccato, MD PhD, Irene Tizianel, Giulio Cabrelle, Amalia Lupi, Alessia Pepe, Cristina Campi, Emilio Quaia, Filippo Crimì
-
📢 Call for Papers: 🎊 Welcome to contribute to the Special Issue "Quality of Life and Follow-Up Care among AYA Cancer Survivors" edited by Dr. Dr. Neetu Chawla and Dr. Sandra A. Mitchell. ⏰ Submission Deadline: 30 April 2025 📌 Find more details here: https://brnw.ch/21wLZrx
-
-
📢 Happy to share the Special Issue "Surgery for Prostate Cancer: Recent Advances and Future Directions" led by Dr. Felix Preisser, Dr. Mike Wenzel and Dr. Benedikt Hoeh. 👏 8 papers have been published! Find more details here👉 https://brnw.ch/21wLQNL
-
-
📢 Happy to share the Special Issue "New Advances in the Treatment of Resectable Non-small Cell Lung Cancer" led by Dr. Francesco Facciolo, Dr. Luca Bertolaccini and Dr. Federico Cappuzzo. 👏 14 papers have been published! Find more details here👉 https://brnw.ch/21wLJ9x
-
-
🌟 Exciting news for all researchers! Dive into our Special Issue: "Health Disparities and Outcomes in Cancer Survivors" https://brnw.ch/21wLI9y 🌍✨ Led by Dr. Claire Jungyoun Han, we're exploring the evolving landscape of cancer survivorship 🎗️ 📈 As more individuals live beyond their cancer diagnosis, it's crucial to address persistent health disparities among diverse populations. From quality of life to access to care, we need your insights! 🧑🔬👩🔬 🗓️ Deadline: 31 May 2025 Submit your original research, reviews, and novel case reports now and help shape a better future for cancer survivors! 💪 #CancerCare #OncologyResearch
-
-
👏 Meet Us at the 2024 CAMO Annual Scientific Meeting! ⏳ 24–26 October 2024 🇨🇦 Ottawa, ON, Canada 🔗 Find more: https://brnw.ch/21wLDg9
-
-
📢Call for Papers! Please consider submitting to this new Special Issue and sharing it with your community. https://brnw.ch/21wLD4N #COPD #lungcancer #secondarypulmonarymetastases #immunotherapy #targetedtherapy
-
-
Current Oncology MDPI hat dies direkt geteilt
Comparto nuevo paper recién publicado con amigos y colegas. Posgrados UDP Felipe Quezada Diaz Erik Manriquez Current Oncology MDPI
Deciphering the Dilemma: Choosing the Optimal Total Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer
mdpi.com